#JITC Short Report: CRISPR-Cas9 disruption of PD-1 enhances activity of universal EGFRvIII CAR T cells in a preclinical model of human glioblastoma https://t.co/T7OTytH2W6 https://t.co/e03ahtJLuZ
New #JITC Short Report: CRISPR-Cas9 disruption of PD-1 enhances activity of universal EGFRvIII CAR T cells in a preclinical model of human glioblastoma https://t.co/T7OTytH2W6 @MarcelaMaus https://t.co/FHdwZVGvsj
RT @celltherapynews: Fascinating research- and a really interesting gif, to boot! https://t.co/tY8Y06oEGO
RT @celltherapynews: Fascinating research- and a really interesting gif, to boot! https://t.co/tY8Y06oEGO
Fascinating research- and a really interesting gif, to boot!
CAR-T cell therapy can be great, but.. the T cells express PD1 and get exhausted. Check out this #GIF I made for a recent @jitcancer paper on this topic (https://t.co/NjHbsUbron) ___ #cancer #immunotherapy #AcademicChatter #AcademicTwitter #scicomm (credit
RT @BobCarterMD: True genetic engineering from neurosurgeon @BryanDChoi! https://t.co/cULtylpMcn
RT @BryanDChoi: Our new study in @jitcancer used CRISPR-Cas9 to knock out PD-1 in CAR T cells, improving efficacy against #glioblastoma. h…
RT @MGHNeuroSci: CAR T-cell therapy for glioblastoma is curbed by surface ligands such as programmed cell death (PD-1). @BryanDChoi, Marcel…
RT @BobCarterMD: True genetic engineering from neurosurgeon @BryanDChoi! https://t.co/cULtylpMcn
RT @BryanDChoi: Our new study in @jitcancer used CRISPR-Cas9 to knock out PD-1 in CAR T cells, improving efficacy against #glioblastoma. h…
#immune_cells_GBM_papers: CRISPR-Cas9 disruption of PD-1 enhances activity of universal EGFRvIII CAR T cells in a preclinical model of human glioblastoma https://t.co/yCkVmDELvC
RT @BryanDChoi: Our new study in @jitcancer used CRISPR-Cas9 to knock out PD-1 in CAR T cells, improving efficacy against #glioblastoma. h…
True genetic engineering from neurosurgeon @BryanDChoi!
RT @BryanDChoi: Our new study in @jitcancer used CRISPR-Cas9 to knock out PD-1 in CAR T cells, improving efficacy against #glioblastoma. h…
RT @BryanDChoi: Our new study in @jitcancer used CRISPR-Cas9 to knock out PD-1 in CAR T cells, improving efficacy against #glioblastoma. h…
RT @WTCNeuroscience: An innovative scheme for cellular immunotherapy to overcome glioblastoma’s immunosuppressive microenvironment. Craft…
Wow!! This is cool!
RT @BryanDChoi: Our new study in @jitcancer used CRISPR-Cas9 to knock out PD-1 in CAR T cells, improving efficacy against #glioblastoma. h…
RT @MGHNeuroSci: CAR T-cell therapy for glioblastoma is curbed by surface ligands such as programmed cell death (PD-1). @BryanDChoi, Marcel…
RT @MGHNeuroSci: CAR T-cell therapy for glioblastoma is curbed by surface ligands such as programmed cell death (PD-1). @BryanDChoi, Marcel…
RT @MGHNeuroSci: CAR T-cell therapy for glioblastoma is curbed by surface ligands such as programmed cell death (PD-1). @BryanDChoi, Marcel…
CAR T-cell therapy for glioblastoma is curbed by surface ligands such as programmed cell death (PD-1). @BryanDChoi, Marcela Maus, MD, Phd, @BobCarterMD, & @WTCNeuroscience use CRISPR-Cas9 to create Car T-cells resistant to PD-1, prolonging survival in
RT @BryanDChoi: Our new study in @jitcancer used CRISPR-Cas9 to knock out PD-1 in CAR T cells, improving efficacy against #glioblastoma. h…
RT @BryanDChoi: Our new study in @jitcancer used CRISPR-Cas9 to knock out PD-1 in CAR T cells, improving efficacy against #glioblastoma. h…
RT @WTCNeuroscience: An innovative scheme for cellular immunotherapy to overcome glioblastoma’s immunosuppressive microenvironment. Craft…
RT @BryanDChoi: Our new study in @jitcancer used CRISPR-Cas9 to knock out PD-1 in CAR T cells, improving efficacy against #glioblastoma. h…
RT @BryanDChoi: Our new study in @jitcancer used CRISPR-Cas9 to knock out PD-1 in CAR T cells, improving efficacy against #glioblastoma. h…
An innovative scheme for cellular immunotherapy to overcome glioblastoma’s immunosuppressive microenvironment. Crafty, Dr. Choi. Great to be part of this team.
Our new study in @jitcancer used CRISPR-Cas9 to knock out PD-1 in CAR T cells, improving efficacy against #glioblastoma. https://t.co/dX146EHMHV Thanks to @MJFzeta, @schmidtsandrea, @WTCNeuroscience, @BobCarterMD and @MarcelaMaus! https://t.co/UYLEIIkJKC